Key result
Low level left vagus nerve stimulation significantly reduced ventricular tachycardia episodes (12.3 vs 74.7, p<0.001) and improved left ventricular ejection fraction compared to no stimulation in a canine model of acute myocardial infarction.
Why the study?
To evaluate whether low-level left vagus nerve stimulation in the early stage of myocardial infarction prevents ventricular arrhythmias, protects cardiac function, and to explore the underlying mechanisms.
Does low level left vagus nerve stimulation prevent ventricular arrhythmias and improve cardiac function in a canine model of acute myocardial infarction?
RCT (n=16)
Randomly divided
No
Does low level left vagus nerve stimulation prevent ventricular arrhythmias and improve cardiac function in a canine model of acute myocardial infarction?
Low-level left vagus nerve stimulation without altering heart rate significantly reduced ventricular arrhythmias and improved left ventricular function in a canine model of acute myocardial infarction.
LLVNS reduced post-MI ventricular arrhythmias and remodeling in dogs; hypothesis-generating, prospective human trials needed before any clinical consideration.
Aims: To evaluate whether low level left vagus nerve stimulation (LLVNS) in early stage of myocardial infarction (MI) could effectively prevent ventricular arrhythmias (VAs) and protect cardiac function, and explore the underlying mechanisms. Methods and Results: After undergoing implantable cardioverter defibrillators (ICD) and left cervical vagal stimulators implantation and MI creation, 16 dogs were randomly divided into three groups: the MI ( n = 6), MI+LLVNS ( n = 5), and sham operation ( n = 5) groups. LLVNS was performed for 3 weeks. VAs, the left ventricular function, the density of the nerve fibers in the infarction area and gene expression profiles were analyzed. Compared with the MI group, dogs in the MI+LLVNS group had a lower VAs incidence ( p < 0.05) and better left ventricular function. LLVNS significantly inhibited excessive sympathetic nerve sprouting with the evidences of decreased density of TH, GAP43 and NF positive nerves ( p < 0.05). The gene expression profiling found a total of 206 genes differentially expressed between MI+LLVNS and MI dogs, mainly involved in cardiac tissue remodeling, cardiac neural remodeling, immune response and apoptosis. These genes, including 55 up-regulated genes and 151 down-regulated genes, showed more protective expressions under LLVNS. Conclusions: This study suggests that LLVNS was delivered without altering heart rate, contributing to reduced incidences of VAs and improved left ventricular function. The potential mechanisms included suppressing cardiac neuronal sprouting, inhibiting excessive sympathetic nerve sprouting and subduing pro-inflammatory responses by regulating gene expressions from a canine experimental study.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2021) conducted an RCT in Acute Myocardial Infarction (n=16). Low level left vagus nerve stimulation (LLVNS) vs. No stimulation (MI group) and sham operation was evaluated on Ventricular tachycardia (VT) episodes (p=<0.001). Low level left vagus nerve stimulation significantly reduced ventricular tachycardia episodes (12.3 vs 74.7, p<0.001) and improved left ventricular ejection fraction compared to no stimulation in a canine model of acute myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: